Pharmasaga Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	164.7	21.87	154.64	36.73
Short-Term Investments	365.35	156.86	-	-
Cash & Short-Term Investments	530.05	178.73	154.64	36.73
Cash Growth	196.57%	15.58%	320.99%	-
Other Receivables	-	0.02	0.06	-
Receivables	-	0.02	0.06	-
Prepaid Expenses	7.73	3.62	0.95	0.07
Other Current Assets	0.02	0.22	-	-
Total Current Assets	537.8	182.59	155.65	36.81
Property, Plant & Equipment	8.59	0.27	-	-
Other Intangible Assets	68.33	75.47	82.34	89.39
Other Long-Term Assets	17.17	16.82	0.09	0.03
Total Assets	631.89	275.15	238.08	126.23
Accrued Expenses	24.06	13.03	6.57	0.19
Current Portion of Leases	1.45	0.26	-	-
Other Current Liabilities	0.29	0.73	0.38	0.01
Total Current Liabilities	25.8	14.02	6.95	0.19
Long-Term Leases	5.55	-	-	-
Total Liabilities	31.35	14.02	6.95	0.19
Common Stock	535.37	282.01	126.47	126.47
Additional Paid-In Capital	146.16	60	13.33	13.33
Retained Earnings	-80.99	-80.88	-41.19	-13.76
Comprehensive Income & Other	-	-	132.52	-
Shareholders' Equity	600.54	261.13	231.13	126.04
Total Liabilities & Equity	631.89	275.15	238.08	126.23
Total Debt	7	0.26	-	-
Net Cash (Debt)	523.05	178.47	154.64	36.73
Net Cash Growth	193.08%	15.41%	320.99%	-
Net Cash Per Share	10.40	4.78	7.12	1.90
Filing Date Shares Outstanding	53.54	28.2	12.65	19.29
Total Common Shares Outstanding	53.54	28.2	12.65	19.29
Working Capital	512	168.57	148.7	36.62
Book Value Per Share	11.22	9.26	18.28	6.53
Tangible Book Value	532.21	185.66	148.79	36.65
Tangible Book Value Per Share	9.94	6.58	11.77	1.90
Machinery	0.3	-	-	-
Leasehold Improvements	1.66	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.